Colin R Simpson1, Julia Hippisley-Cox, Aziz Sheikh. 1. Allergy and Respiratory Research Group, Centre for Population Health Sciences, University of Edinburgh, Medical School (Doorway 3), Teviot Place, Edinburgh. c.simpson@ed.ac.uk
Abstract
BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) constitute a substantial burden to healthcare services. Analysis of national healthcare datasets offers the possibility to advance understanding about the changing epidemiology of COPD. AIM: To investigate the epidemiology of physician-diagnosed COPD in general practice. DESIGN OF STUDY: Cross-sectional study. SETTINGS: A total of 422 general practices in England contributing to the QRESEARCH database. METHOD: Data were extracted on 2.8 million patients, including age, sex, socioeconomic status, and geographical area. Trends over time for recorded physician diagnosis of COPD were analysed (2001-2005). RESULTS: There was little change over time in the incidence rate of COPD (2005: 2.0 per 1000 patient-years, 95% confidence interval [CI] = 2.0 to 2.1), but a significant increase in lifetime prevalence rate (2001: 13.5 per 1000 patients [95% CI = 13.4 to 13.7]; 2005: 16.8 [95% CI = 16.7 to 17.0]; P<0.001). In 2005, 51 804 individuals or one in 59 people in England were recorded with physician-diagnosed COPD. The most deprived people (31.1 per 1000 patients; 95% CI = 30.6 to 31.7) and those living in the north east of England (29.2 per 1000 patients; 95% CI = 28.4 to 30.1) had the highest prevalence. The observed reduction in the rate of smoking by patients with COPD (overall decrease: 2.5%; P<0.001) varied according to socioeconomic group (most affluent: 6.5% decrease, most deprived: 1.3% decrease). CONCLUSION: Given the peak in the incidence rate of COPD, we may be approaching the summit of COPD incidence and prevalence in England. However, the number of people affected remains high and poses a major challenge for health services, particularly those in the north east of the country and in the most deprived communities in England. The very limited decrease in smoking rates among the more deprived groups of patients with COPD is also a cause for concern.
BACKGROUND:Patients with chronic obstructive pulmonary disease (COPD) constitute a substantial burden to healthcare services. Analysis of national healthcare datasets offers the possibility to advance understanding about the changing epidemiology of COPD. AIM: To investigate the epidemiology of physician-diagnosed COPD in general practice. DESIGN OF STUDY: Cross-sectional study. SETTINGS: A total of 422 general practices in England contributing to the QRESEARCH database. METHOD: Data were extracted on 2.8 million patients, including age, sex, socioeconomic status, and geographical area. Trends over time for recorded physician diagnosis of COPD were analysed (2001-2005). RESULTS: There was little change over time in the incidence rate of COPD (2005: 2.0 per 1000 patient-years, 95% confidence interval [CI] = 2.0 to 2.1), but a significant increase in lifetime prevalence rate (2001: 13.5 per 1000 patients [95% CI = 13.4 to 13.7]; 2005: 16.8 [95% CI = 16.7 to 17.0]; P<0.001). In 2005, 51 804 individuals or one in 59 people in England were recorded with physician-diagnosed COPD. The most deprived people (31.1 per 1000 patients; 95% CI = 30.6 to 31.7) and those living in the north east of England (29.2 per 1000 patients; 95% CI = 28.4 to 30.1) had the highest prevalence. The observed reduction in the rate of smoking by patients with COPD (overall decrease: 2.5%; P<0.001) varied according to socioeconomic group (most affluent: 6.5% decrease, most deprived: 1.3% decrease). CONCLUSION: Given the peak in the incidence rate of COPD, we may be approaching the summit of COPD incidence and prevalence in England. However, the number of people affected remains high and poses a major challenge for health services, particularly those in the north east of the country and in the most deprived communities in England. The very limited decrease in smoking rates among the more deprived groups of patients with COPD is also a cause for concern.
Authors: Roberto de Marco; Simone Accordini; Isa Cerveri; Angelo Corsico; Josep M Antó; Nino Künzli; Christer Janson; Jordi Sunyer; Deborah Jarvis; Susan Chinn; Paul Vermeire; Cecilie Svanes; Ursula Ackermann-Liebrich; Thorarinn Gislason; Joachim Heinrich; Bénédicte Leynaert; Françoise Neukirch; Jan P Schouten; Matthias Wjst; Peter Burney Journal: Am J Respir Crit Care Med Date: 2006-09-28 Impact factor: 21.405
Authors: Daniel Kotz; Colin R Simpson; Wolfgang Viechtbauer; Onno C P van Schayck; Aziz Sheikh Journal: NPJ Prim Care Respir Med Date: 2014-05-20 Impact factor: 2.871
Authors: Koosha Ghazi-Moghadam; Hasan Mete Inançlı; Nazanin Bazazy; Peter K Plinkert; Thomas Efferth; Serkan Sertel Journal: Pharmaceuticals (Basel) Date: 2012-08-20